EDITAS MEDICINE, INC. Interest Paid, Excluding Capitalized Interest, Operating Activities
EDITAS MEDICINE, INC. (EDIT) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $13.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2018-03-08
- EDITAS MEDICINE, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2017 was $13.00K, a 97.20% decline from fiscal 2016.
- EDITAS MEDICINE, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2016 was $465.00K, a 410.99% increase from fiscal 2015.
- EDITAS MEDICINE, INC. interest paid, excluding capitalized interest, operating activities for fiscal 2015 was $91.00K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|
| 2017-12-31 | $13.00K 10-K · filed 2018-03-08 |
| 2016-12-31 | $465.00K 10-K · filed 2018-03-08 |
| 2015-12-31 | $91.00K 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |